Cargando…
Increased Soluble CD155 in the Serum of Cancer Patients
Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many human tumors significantly upregulate the express...
Autores principales: | Iguchi-Manaka, Akiko, Okumura, Genki, Kojima, Hiroshi, Cho, Yukiko, Hirochika, Rei, Bando, Hiroko, Sato, Toyomi, Yoshikawa, Hiroyuki, Hara, Hisato, Shibuya, Akira, Shibuya, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822883/ https://www.ncbi.nlm.nih.gov/pubmed/27049654 http://dx.doi.org/10.1371/journal.pone.0152982 |
Ejemplares similares
-
High expression of soluble CD155 in estrogen receptor-negative breast cancer
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2019) -
Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020) -
CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT
por: Matsuo, Tomohei, et al.
Publicado: (2022) -
Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
por: Nagumo, Yoko, et al.
Publicado: (2014) -
Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease
por: Kanaya, Minoru, et al.
Publicado: (2016)